September 23, 2020 - Global Pharma Times

Bioclinica, an integrated solutions provider of clinical life science and technology expertise, delivering powerful insight into clinical trial development in bringing new therapies to people...

ADHD Study Reveals Unique Genetic Differences in African American Patients with the Condition

PR Newswire

September 23, 2020

Researchers from Children's Hospital of Philadelphia (CHOP) have shown there may be key genetic differences in the causes of attention-deficit hyperactivity disorder (ADHD) between African Americans and...

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

PR Newswire

September 23, 2020

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735,...

Dr. Manjiri Bakre Awarded ‘Health Tech Innovator of the Year’

Newsvoir

September 23, 2020

Dr. Manjiri Bakre, Founder & CEO OncoStem Diagnostics, was awarded 'Health Tech Innovator of the Year' by ET Healthworld - Intelligent Health & Tech awards...

Breaking News

Samarpit Kanwatia to amaze his clients with a newly designed dry-fit t-shirt

Samarpit Kanwatia, founder of Sarv Mangal Ho launches exclusive multipurpose mask

FDA approves Roche’s Actemra/RoActemra treatment for rare lung disease

Amgen to acquire Five Prime Therapeutics for approximately $1.9bn

Novartis signs agreement to manufacture CureVac’s COVID-19 vaccine

UK government invests £5m in COVID-19 mRNA vaccine library

ravkoo™, Digital Pharmacy to Deploy medifriendRx Prescription…

Takeda agree $856m deal with Ovid to take over soticlestat development

énergie fitness, UK’s premium gym chain franchise brings a business opportunity for Indian Entrepreneurs in 2021

Beyond Batten Disease Foundation partners with Actelion on development of combination treatment

Bioclinica Partners with GI Reviewers in Developing Advanced Technologies

ADHD Study Reveals Unique Genetic Differences in African American Patients with the Condition

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate

Dr. Manjiri Bakre Awarded ‘Health Tech Innovator of the Year’